Janet Grove - Feb 18, 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Bruce Colwill, attorney-in-fact for Ms. Janet P. Grove
Stock symbol
INM
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 07:16 PM
Previous filing
Feb 22, 2022
Next filing
Dec 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +14K $0.00 14K Feb 18, 2022 Common shares 14K $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 02/18/2022 with 390 stock options vesting on the 18th day of each of the 35 months commencing March 18, 2022 through January 18, 2025 and 350 stock options will vest on February 18, 2025.